ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2295

Burden of Systemic Lupus Erythematosus Among Korean Women in Childbearing Years Based on the National Health Insurance Service Data

Min Kyung Chung 1, Jin Su Park 2, Hyun Sun Lim 2, Chan Hee Lee 2 and Jisoo Lee1, 1Division of Rheumatology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Republic of Korea, 2Division of Rheumatology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Comorbidity, medication and pregnancy, Reproductive Health, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Reproductive Issues In Rheumatic Disorders Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Most women with systemic lupus erythematosus (SLE) are diagnosed with the disease in their reproductive ages, but the burden of SLE among women in childbearing years remains incompletely understood. We aimed to investigate the burden of SLE among Korean women in childbearing years in terms of prevalence and incidence of disease, prevalence of comorbidity, medication dispensing, and pregnancy and delivery rate.

Methods: From National Health Insurance Service data during 2009-2016, women between 20-44 years of childbearing years were identified. Among these women, the prevalence and incidence of SLE were estimated. Women without chronic diseases (CD) or rheumatic diseases including SLE, rheumatoid arthritis, and ankylosing spondylitis were defined as controls. Prevalence of CD including cancer (Ca), diabetes mellitus (DM), hypertension (HTN), and hyperlipidemia (HLD) was compared in SLE women and controls. Medication uses including NSAIDs, corticosteroids (CSs), and conventional (c) disease-modifying anti-rheumatic drugs (DMARDs), pregnancy and delivery rates in women with SLE were compared with controls.

Results: Total 12,756 women with SLE and 208,941 controls were identified. The overall prevalence of SLE during 2009-2016 was 138.5 (95% CI 136.1-140.9) per 100,000 and overall incidence of SLE was 49.1 (95% CI 47.7-50.5) per 100,000 females in childbearing years during 2011-2016. SLE women had significantly increased prevalence of CD compared with the controls in the same age group (60.4% vs 25.6%, odds ratio (OR) 5.4, p< 0.0001). Each chronic disease including Ca (6.3% vs 4.2%, OR 4.2), DM (9.7% vs 6.0%, OR 1.9), HTN (35.2% vs 8.2%, OR 8.0), and HLD (38.3% vs 16.6%, OR 3.6) were all more prevalent in SLE women compared with the controls (p< 0.001). The use of any rheumatic diseases related medications including NSAIDs, CSs, cDMARDs were more frequent in women with SLE than controls (NSAIDs; 53.6% vs 21.8%, CSs; 81.0% vs 4.3%, cDMARDs; 89.0% vs 0.4%, all p< 0.001). Although pregnancy rate showed no difference between SLE women and controls (22.1% vs 19.3%, OR=0.97, p=0.38), delivery rate was significantly lower in SLE women compared with controls (18.7% vs 20.3%, OR 0.8, p< 0.001).

Conclusion: High prevalence and incidence, increased rates of comorbidities and medication use, and decreased odds to have successful delivery are causes of a significant burden in Korean women with SLE during their childbearing years.


ACR2019_Table1

Prevalence of chronic diseases among women with SLE in childbearing age between 20-44 years during 2009-2016


Disclosure: M. Chung, None; J. Park, None; H. Lim, None; C. Lee, None; J. Lee, None.

To cite this abstract in AMA style:

Chung M, Park J, Lim H, Lee C, Lee J. Burden of Systemic Lupus Erythematosus Among Korean Women in Childbearing Years Based on the National Health Insurance Service Data [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/burden-of-systemic-lupus-erythematosus-among-korean-women-in-childbearing-years-based-on-the-national-health-insurance-service-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/burden-of-systemic-lupus-erythematosus-among-korean-women-in-childbearing-years-based-on-the-national-health-insurance-service-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology